CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | 0.0% | 2,786 | -2.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 2,844 | -21.5% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 3,623 | +18.2% | 0.00% | – |
| Q2 2017 | $2,000 | -81.8% | 3,065 | -50.4% | 0.00% | – |
| Q1 2017 | $11,000 | +37.5% | 6,182 | -0.8% | 0.00% | – |
| Q4 2016 | $8,000 | +60.0% | 6,233 | +18.9% | 0.00% | – |
| Q3 2016 | $5,000 | +66.7% | 5,242 | +60.2% | 0.00% | – |
| Q2 2016 | $3,000 | -25.0% | 3,272 | +0.3% | 0.00% | – |
| Q1 2016 | $4,000 | -20.0% | 3,263 | -2.7% | 0.00% | – |
| Q4 2015 | $5,000 | -28.6% | 3,355 | -3.4% | 0.00% | – |
| Q3 2015 | $7,000 | -61.1% | 3,473 | -1.7% | 0.00% | – |
| Q2 2015 | $18,000 | -18.2% | 3,534 | -51.6% | 0.00% | – |
| Q1 2015 | $22,000 | – | 7,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAM Investors, LLC | 670,593 | $3,401,000 | 0.45% |
| Prospera Financial Services Inc | 184,100 | $236,000 | 0.05% |
| HighTower Advisors, LLC | 1,047,731 | $1,257,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 15,142 | $18,000 | 0.01% |
| TEACHERS ADVISORS, LLC | 298,781 | $1,820,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 724,455 | $4,412,000 | 0.00% |
| Virtu KCG Holdings LLC | 90,490 | $109,000 | 0.00% |
| FIRST FOUNDATION ADVISORS | 10,000 | $12,000 | 0.00% |
| Acrospire Investment Management LLC | 2,300 | $3,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |